Abstract
Objective
The primary aim of the study was to analyze the endometrioma recurrence rate in patients who underwent laparoscopic excision followed by postoperative long-term regimen of oral contraceptives (OCs).
Materials and methods
168 patients who underwent a conservative laparoscopic surgery for endometrioma, during the period between September 2009 and August 2010 in three university hospitals were studied. A long-term OCs therapy was offered to all women following surgery. Patients were randomly divided into three groups according to different progestins used (desogestrel, gestodene, dienogest). Women who refused a postoperative hormonal therapy served as control. Follow-up visits and transvaginal scan were planned at 1, 3, 6, 12, and 24 months after surgery. All patients who showed an ultrasound persistence of the endometrioma at 1 month follow-up were excluded from clinical analysis.
Results
Of the 168 patients, 131 completed the 24 months follow-up. Endometrioma recurrence was found in 21 (12.5 %) of all patients, it was unilateral in 17 cases while bilateral in 4 cases. The rate of recurrent endometrioma was statistically significant in non-users compared to the long-term OCs treated patients.
Conclusion
The current data suggest the usefulness of long-term OCs regimen after conservative surgery for the prevention of ovarian endometrioma recurrence. As a statistical significant difference could not be observed between OCs groups, further study on the individual molecules is required in order to really understand the effect of each of them.
Similar content being viewed by others
References
Eskenazi B, Warner ML (1997) Epidemiology of endometriosis. Obstet Gynecol Clin North Am 24:235–258
Seracchioli R, Mabrouk M, Frascà C et al (2010) Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial. Fertil Steril 93:52–56
The Practice Committee of the American Society for Reproductive Medicine (2008) Treatment of pelvic pain associated with endometriosis. Fertil Steril 90(Suppl 5):S260–S269
Exacoustos C, Zupi E, Amadio A et al (2006) Recurrence of endometriomas after laparoscopic removal: sonographic and clinical follow-up and indication for second surgery. J Minim Invasive Gynecol 13:281–288
Vercellini P, Somigliana E, Viganò P, De Matteis S, Barbara G, Fedele L (2010) Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence. Reprod Biomed Online 21:259–265
Koga K, Takemura Y, Osuga Y et al (2006) Recurrence of ovarian endometrioma after laparoscopic excision. Hum Reprod 21:2171–2174
Jee BC, Lee JY, Suh CS et al (2009) Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery. Fertil Steril 91:40–45
Kikuchi I, Takeuchi H, Kitade M et al (2006) Recurrence rate of endometriomas following a laparoscopic cystectomy. Acta Obstet Gynecol Scand 85:1120–1124
Liu X, Yuan L, Shen F et al (2007) Patterns of and risk factors for recurrence in women with ovarian endometriosis. Obstet Gynecol 109:1411–1420
Vercellini P, Somigliana E, Daguati R et al (2008) Postoperative oral contraceptive exposure and risk of endometrioma recurrence. Am J Obstet Gynecol 198:504.e1–504.e5
ACOG Committee on Practice Bulletins-Gynaecology. ACOG practice bulletin. Medical management of endometriosis. Number 11, December 1999 (replaces technical bulletin number 184, September 1993) (2000) Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet 71(2):183–196
Donnez J, Nisolle M, Gillet N et al (1996) Large ovarian endometriomas. Hum Reprod 11:641–646
Sutton CJ, Ewen SP, Jacobs SA et al (1997) Laser laparoscopic surgery in the treatment of ovarian endometriomas. J Am Assoc Gynecol Laparosc 4:319–323
Yuen PM, Yu KM, Yip SK et al (1997) A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses. Am J Obstet Gynecol 177:109–114
Luciano AA, Lowney J, Jacobs SL (1992) Endoscopic treatment of endometriosis-associated infertility. Therapeutic, economic and social benefits. J Reprod Med 37:573–576
Chapron C, Vercellini P, Barakat H et al (2002) Management of ovarian endometriomas. Hum Reprod Update 8:591–597
Fedele L, Bianchi S, Zanconato G et al (2006) Laparoscopic excision of recurrent endometriomas: long-term outcome and comparison with primary surgery. Fertil Steril 85:694–699
Nezhat F, Nezhat C, Allan CJ, Metzger DA, Sears DL (1992) Clinical and histologic classification of endometriomas. Implications for a mechanism of pathogenesis. J Reprod Med 37:771–776
Jain S, Dalton ME (1999) Chocolate cyst from ovarian follicles. Fertil Steril 72:852–856
Busacca M, Riparini J, Somigliana E et al (2006) Postsurgical ovarian failure after laparoscopic excision of bilateral endometriomas. Am J Obstet Gynecol 195:421–425
Somigliana E, Vercellini P, Viganò P et al (2006) Should endometriomas be treated prior to IVF-ICSI cycles? Hum Reprod Update 12:57–64
Petraglia F, Hornung D, Seitz C, Faustmann T, Gerlinger C, Luisi S, Lazzeri L, Strowitzki T (2012) Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment. Arch Gynecol Obstet 285:167–173
Seracchioli R, Mabrouk M, Manuzzi L, Vicenzi C, Frascà C, Elmakky A, Venturoli S (2009) Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom recurrence after conservative surgery for endometriosis. Human Reprod 24:2729–2735
Vercellini P, Fedele L, Pietropaolo G et al (2003) Progestogens for endometriosis: forward to the past. Hum reprod Update 9:387–396
Foster RH, Wilde MI (1998) Dienogest. Drugs 56:825–833
Schindler AE (2011) Dienogest in long-term treatment of endometriosis. Int J Womens Health 3:175–184
The American Fertility Society (1985) Revised American fertility society classification of endometriosis. Fertil Steril 43:351–352
Mais V, Guerriero S, Ajossa S, Angiolucci M, Paoletti AM, Melis GB (1993) The efficiency of transvaginal ultrasonography in the diagnosis of endometrioma. Fertil Steril 60:776–780
Takamura M, Koga K, Osuga Y et al (2009) Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision. Hum Reprod 24:3042–3048
Missmer SA, Cramer DW (2003) The epidemiology of endometriosis. Obstet Gynecol Clin North Am 30:1–19
Viganò P, Parazzini F, Somigliana E et al (2004) Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynecol 18:177–200
Rodgers AK, Falcone T (2008) Treatment strategies for endometriosis. Expert Opin Pharmacother 9:243–255
Meresman GF, Auge L, Baranao RI et al (2002) Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril 77:1141–1147
Vercellini P, Somigliana E, Vigano P et al (2008) Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol 22:275–306
Vercellini P, Frontino G, De Giorgi O et al (2003) Continuous use of an oral contraceptive for endometriosis- associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 80:560–563
Muzii L, Marana R, Caruana P et al (2000) Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomized trial. Am J Obstet Gynecol 183:588–592
Vercellini P, Eskenazi B, Consonni D, Somigliana E, Parazzini F, Abbiati A, Fedele L (2011) Oral contraceptives and risk of endometriosis: a systematic review and meta-analysis. Hum Reprod Update 17:159–170
Meresman GF, Bilotas M, Abello V, Buquet R, Tesone M, Sueldo C (2005) Effects of aromatase inhibitors on proliferation and apoptosis in eutopic endometrial cell cultures from patients with endometriosis. Fertil Steril 84:459–463
Maia H Jr, Casoy J, Correia T, Freitas LA, Pimentel K, Athayde C (2008) The effect of oral contraceptives on aromatase expression in the eutopic endometrium of patients with endometriosis. Gynecol Endocrinol 24:123
Maia H Jr, Casoy J, Valente Filho J (2009) Is aromatase expression in the endometrium the cause of endometriosis and related infertility? Gynecol Endocrinol 25:253–257
Oettel M, Breitbarth H, Elger W et al (1999) The pharmacological profile of dienogest. Eur J Contracept Reprod Health Care 4:2–13
Moore C, Carol W, Graser T, Mellinger U, Walter F (1999) Influence of dienogest on ovulation in young fertile women. Clin Drug Invest 18:271–278
Horie S, Harada T, Mitsunari M, Taniguchi F, Iwabe T, Terakawa N (2005) Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells. Fertil Steril 83:1530–1535
Herkert O, Kuhl H, Sandow J, Busse R, Schini-Kerth VB (2001) Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor. Circulation 104:2826–2831
Köhler G, Faustmann TA, Gerlinger C, Seitz C, Mueck AO (2011) A dose-ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis. Erratum in: Int J Gynaecol Obstet 112:257
Evers LH, Dunselman GA, Land JA, Bouckaert PX (1998) Endometriosis: prevention of recurrence. In: Kempers RD, Cohen J, Haney AF, Younger JB (eds) Fertility and reproduction medicine, vol 1183. Excerpta medica, International congress series, Amsterdam, pp 387–396
Vercellini P, Somigliana E, Daguati R et al (2009) The second time around: reproductive performance after repetitive versus primary surgery for endometriosis. Fertil Steril 92:1253–1255
Vercellini P, Somigliana E, Vigano’ P et al (2009) Surgery for endometriosis-associated infertility: a pragmatic approach. Hum Reprod 24:254–269
Vercellini P, Somigliana E, Vigano’ P et al (2009) The effect of second-line surgery on reproductive performance of women with recurrent endometriosis. Acta Obstet Gynecol Scand 88:1074–1082
Missmer SA, Hankinson SE, Spiegelman D et al (2004) Reproductive history and endometriosis among premenopausal women. Obstet Gynecol 104:965–974
Conflict of interest
The authors declare to have no financial relationship with any organization or Companies. Authors also declare to have had full control of all primary data and that all coauthors agree to allow the journal to review their data if requested.
Author information
Authors and Affiliations
Corresponding author
Additional information
G. Cucinella and R. Granese are equal first authors.
Rights and permissions
About this article
Cite this article
Cucinella, G., Granese, R., Calagna, G. et al. Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference?. Arch Gynecol Obstet 288, 821–827 (2013). https://doi.org/10.1007/s00404-013-2841-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-013-2841-9